Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
Abroad (travel likely)RecruitingPHASE2
Conditions
NSCLC · Neoadjuvant Immunotherapy · Low Dose Radiotherapy · Sintilimab
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Anhui Provincial Cancer Hospital, Hefei, Anhui, China
Contact: Principal Investigator (Shuanghu Yuan, MD.,PhD.)